Floatz logo

METHOTREXATE

Chronic Stable Angina

Stephen McSwigganSmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Chronic Stable Angina cohort.

Asset / SponsorPhaseRating
Metformin
Wake Forest University Health Sciences
Phase 4BBB
Danhong
China Academy of Chinese Medical Sciences
Phase 4BB
MERCAPTOPURINE ANHYDROUS
Stephen McSwiggan
Phase 4BB
Nicorandil
Ferozsons Laboratories Ltd.
Phase 4BB
ATENOLOL
Ferozsons Laboratories Ltd.
Phase 4BB

View all 18 →

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →